APO RESEARCH · REPORT
Covid Testing Kit
COVID-19 testing involves analysing samples that indicate the present or past presence of SARS-CoV-2. The two main branches detect either the presence of the virus or antibodies produced in response to infection.
Product & engineering
Understand the product.
COVID-19 testing involves analysing samples that indicate the present or past presence of SARS-CoV-2. The two main branches detect either the presence of the virus or antibodies produced in response to infection.
Tests for viral presence are used to diagnose illness and to allow public health authorities to identify and contain outbreaks as quickly as possible. Antibody tests instead support attempts to estimate the prevalence of disease within a population. Another, speculative use is to identify individuals who the antibodies have rendered immune to the disease, although research has yet to confirm that a positive test confers such immunity.
Individual jurisdictions have adopted a broad range of testing protocols. They vary in choosing whom to test, how often to test, analysis protocols, sample collection and the uses of test results. This variation has likely significantly impacted countries' reported statistics, including case fatality rates and the age distribution of cases, due to sampling bias.
Testing is often performed in automated, high-throughput centralized medical laboratories by medical laboratory scientists. Alternatively, point-of-care testing can be done in physician's offices, workplaces or transit hubs.
Selected research
Market Analysis & Forecast
Global Covid Testing Kit Market Analysis and Forecast 2026-2032
Market perspective
COVID-19 testing involves analysing samples that indicate the present or past presence of SARS-CoV-2. The two main branches detect either the presence of the virus or antibodies produced in response to infection.
Tests for viral presence are used to diagnose illness and to allow public health authorities to identify and contain outbreaks as quickly as possible. Antibody tests instead support attempts to estimate the prevalence of disease within a population. Another, speculative use is to identify individuals who the antibodies have rendered immune to the disease, although research has yet to confirm that a positive test confers such immunity.
Individual jurisdictions have adopted a broad range of testing protocols. They vary in choosing whom to test, how often to test, analysis protocols, sample collection and the uses of test results. This variation has likely significantly impacted countries' reported statistics, including case fatality rates and the age distribution of cases, due to sampling bias.
Read the full market overview
Testing is often performed in automated, high-throughput centralized medical laboratories by medical laboratory scientists. Alternatively, point-of-care testing can be done in physician's offices, workplaces or transit hubs.
According to our prediction, Asia Pacific is the largest consumer of Covid Testing Kit in global market, with an estimated consumption market share of 69.22% on June.The second place is Europe, following Asia Pacific with the consumption market share of 15.88% on June.
The classification of Covid Testing Kit includes Nucleic Acid Testing and Antibody Testing. The share of Nucleic Acid Testing in the market is 93.05% on June.
The application of Covid Testing Kit includes hospitals and scientific research. In addition, the market share of scientific research is 61.84% on June.
Report Includes
This report presents an overview of global market for Covid Testing Kit, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Covid Testing Kit, also provides the revenue of main regions and countries. Of the upcoming market potential for Covid Testing Kit, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Covid Testing Kit revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Covid Testing Kit market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Covid Testing Kit revenue, projected growth trends, production technology, application and end-user industry.
Covid Testing Kit Segment by Company
Cellex
Abbott
Roche
BioMedomics
BD
Safecare Bio-Tech
Mayo Clinic Laboratories
Chembio Diagnostics
Mount Sinai Laboratory
Ortho Clinical Diagnostics
Zhejiang Orient Gene Biotech
Innovita Biological Technology
Guangzhou Wondfo Biotech
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)
ADVAITE
Covid Testing Kit Segment by Type
Nucleic Acid Testing
Antibody Testing
Covid Testing Kit Segment by Application
Hospitals
Scientific Research
Covid Testing Kit Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Covid Testing Kit market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Covid Testing Kit and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Covid Testing Kit.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Covid Testing Kit in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Covid Testing Kit company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Covid Testing Kit revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Nucleic Acid Testing
- Antibody Testing
Applications
- Hospitals
- Scientific Research
Companies covered
- Cellex
- Abbott
- Roche
- BioMedomics
- BD
- Safecare Bio-Tech
- Mayo Clinic Laboratories
- Chembio Diagnostics
- Mount Sinai Laboratory
- Ortho Clinical Diagnostics
- Zhejiang Orient Gene Biotech
- Innovita Biological Technology
- Guangzhou Wondfo Biotech
- Guangdong Hecin-Scientific
- Dynamiker Biotechnology (Tianjin)
- ADVAITE
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Covid Testing Kit Market by Type
- 1.2.1 Global Covid Testing Kit Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Nucleic Acid Testing
- 1.2.3 Antibody Testing
- 1.3 Covid Testing Kit Market by Application
- 1.3.1 Global Covid Testing Kit Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospitals
- 1.3.3 Scientific Research
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Covid Testing Kit Market Dynamics
- 2.1 Covid Testing Kit Industry Trends
- 2.2 Covid Testing Kit Industry Drivers
- 2.3 Covid Testing Kit Industry Opportunities and Challenges
- 2.4 Covid Testing Kit Industry Restraints
3 Global Growth Perspective
- 3.1 Global Covid Testing Kit Market Perspective (2021-2032)
- 3.2 Global Covid Testing Kit Growth Trends by Region
- 3.2.1 Global Covid Testing Kit Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Covid Testing Kit Market Size by Region (2021-2026)
- 3.2.3 Global Covid Testing Kit Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Covid Testing Kit Revenue by Players
- 4.1.1 Global Covid Testing Kit Revenue by Players (2021-2026)
- 4.1.2 Global Covid Testing Kit Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Covid Testing Kit Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Covid Testing Kit Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Covid Testing Kit Key Players Headquarters & Area Served
- 4.4 Global Covid Testing Kit Players, Product Type & Application
- 4.5 Global Covid Testing Kit Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Covid Testing Kit Market CR5 and HHI
- 4.6.3 2025 Covid Testing Kit Tier 1, Tier 2, and Tier 3
5 Covid Testing Kit Market Size by Type
- 5.1 Global Covid Testing Kit Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Covid Testing Kit Revenue by Type (2021-2032)
- 5.3 Global Covid Testing Kit Revenue Market Share by Type (2021-2032)
6 Covid Testing Kit Market Size by Application
- 6.1 Global Covid Testing Kit Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Covid Testing Kit Revenue by Application (2021-2032)
- 6.3 Global Covid Testing Kit Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Cellex
- 7.1.1 Cellex Company Information
- 7.1.2 Cellex Business Overview
- 7.1.3 Cellex Covid Testing Kit Revenue and Gross Margin (2021-2026)
- 7.1.4 Cellex Covid Testing Kit Product Portfolio
- 7.1.5 Cellex Recent Developments
- 7.2 Abbott
- 7.2.1 Abbott Company Information
- 7.2.2 Abbott Business Overview
- 7.2.3 Abbott Covid Testing Kit Revenue and Gross Margin (2021-2026)
- 7.2.4 Abbott Covid Testing Kit Product Portfolio
- 7.2.5 Abbott Recent Developments
- 7.3 Roche
- 7.3.1 Roche Company Information
- 7.3.2 Roche Business Overview
- 7.3.3 Roche Covid Testing Kit Revenue and Gross Margin (2021-2026)
- 7.3.4 Roche Covid Testing Kit Product Portfolio
- 7.3.5 Roche Recent Developments
- 7.4 BioMedomics
- 7.4.1 BioMedomics Company Information
- 7.4.2 BioMedomics Business Overview
- 7.4.3 BioMedomics Covid Testing Kit Revenue and Gross Margin (2021-2026)
- 7.4.4 BioMedomics Covid Testing Kit Product Portfolio
- 7.4.5 BioMedomics Recent Developments
- 7.5 BD
- 7.5.1 BD Company Information
- 7.5.2 BD Business Overview
- 7.5.3 BD Covid Testing Kit Revenue and Gross Margin (2021-2026)
- 7.5.4 BD Covid Testing Kit Product Portfolio
- 7.5.5 BD Recent Developments
- 7.6 Safecare Bio-Tech
- 7.6.1 Safecare Bio-Tech Company Information
- 7.6.2 Safecare Bio-Tech Business Overview
- 7.6.3 Safecare Bio-Tech Covid Testing Kit Revenue and Gross Margin (2021-2026)
- 7.6.4 Safecare Bio-Tech Covid Testing Kit Product Portfolio
- 7.6.5 Safecare Bio-Tech Recent Developments
- 7.7 Mayo Clinic Laboratories
- 7.7.1 Mayo Clinic Laboratories Company Information
- 7.7.2 Mayo Clinic Laboratories Business Overview
- 7.7.3 Mayo Clinic Laboratories Covid Testing Kit Revenue and Gross Margin (2021-2026)
- 7.7.4 Mayo Clinic Laboratories Covid Testing Kit Product Portfolio
- 7.7.5 Mayo Clinic Laboratories Recent Developments
- 7.8 Chembio Diagnostics
- 7.8.1 Chembio Diagnostics Company Information
- 7.8.2 Chembio Diagnostics Business Overview
- 7.8.3 Chembio Diagnostics Covid Testing Kit Revenue and Gross Margin (2021-2026)
- 7.8.4 Chembio Diagnostics Covid Testing Kit Product Portfolio
- 7.8.5 Chembio Diagnostics Recent Developments
- 7.9 Mount Sinai Laboratory
- 7.9.1 Mount Sinai Laboratory Company Information
- 7.9.2 Mount Sinai Laboratory Business Overview
- 7.9.3 Mount Sinai Laboratory Covid Testing Kit Revenue and Gross Margin (2021-2026)
- 7.9.4 Mount Sinai Laboratory Covid Testing Kit Product Portfolio
- 7.9.5 Mount Sinai Laboratory Recent Developments
- 7.10 Ortho Clinical Diagnostics
- 7.10.1 Ortho Clinical Diagnostics Company Information
- 7.10.2 Ortho Clinical Diagnostics Business Overview
- 7.10.3 Ortho Clinical Diagnostics Covid Testing Kit Revenue and Gross Margin (2021-2026)
- 7.10.4 Ortho Clinical Diagnostics Covid Testing Kit Product Portfolio
- 7.10.5 Ortho Clinical Diagnostics Recent Developments
- 7.11 Zhejiang Orient Gene Biotech
- 7.11.1 Zhejiang Orient Gene Biotech Company Information
- 7.11.2 Zhejiang Orient Gene Biotech Business Overview
- 7.11.3 Zhejiang Orient Gene Biotech Covid Testing Kit Revenue and Gross Margin (2021-2026)
- 7.11.4 Zhejiang Orient Gene Biotech Covid Testing Kit Product Portfolio
- 7.11.5 Zhejiang Orient Gene Biotech Recent Developments
- 7.12 Innovita Biological Technology
- 7.12.1 Innovita Biological Technology Company Information
- 7.12.2 Innovita Biological Technology Business Overview
- 7.12.3 Innovita Biological Technology Covid Testing Kit Revenue and Gross Margin (2021-2026)
- 7.12.4 Innovita Biological Technology Covid Testing Kit Product Portfolio
- 7.12.5 Innovita Biological Technology Recent Developments
- 7.13 Guangzhou Wondfo Biotech
- 7.13.1 Guangzhou Wondfo Biotech Company Information
- 7.13.2 Guangzhou Wondfo Biotech Business Overview
- 7.13.3 Guangzhou Wondfo Biotech Covid Testing Kit Revenue and Gross Margin (2021-2026)
- 7.13.4 Guangzhou Wondfo Biotech Covid Testing Kit Product Portfolio
- 7.13.5 Guangzhou Wondfo Biotech Recent Developments
- 7.14 Guangdong Hecin-Scientific
- 7.14.1 Guangdong Hecin-Scientific Company Information
- 7.14.2 Guangdong Hecin-Scientific Business Overview
- 7.14.3 Guangdong Hecin-Scientific Covid Testing Kit Revenue and Gross Margin (2021-2026)
- 7.14.4 Guangdong Hecin-Scientific Covid Testing Kit Product Portfolio
- 7.14.5 Guangdong Hecin-Scientific Recent Developments
- 7.15 Dynamiker Biotechnology (Tianjin)
- 7.15.1 Dynamiker Biotechnology (Tianjin) Company Information
- 7.15.2 Dynamiker Biotechnology (Tianjin) Business Overview
- 7.15.3 Dynamiker Biotechnology (Tianjin) Covid Testing Kit Revenue and Gross Margin (2021-2026)
- 7.15.4 Dynamiker Biotechnology (Tianjin) Covid Testing Kit Product Portfolio
- 7.15.5 Dynamiker Biotechnology (Tianjin) Recent Developments
- 7.16 ADVAITE
- 7.16.1 ADVAITE Company Information
- 7.16.2 ADVAITE Business Overview
- 7.16.3 ADVAITE Covid Testing Kit Revenue and Gross Margin (2021-2026)
- 7.16.4 ADVAITE Covid Testing Kit Product Portfolio
- 7.16.5 ADVAITE Recent Developments
8 North America
- 8.1 North America Covid Testing Kit Revenue (2021-2032)
- 8.2 North America Covid Testing Kit Revenue by Type (2021-2032)
- 8.2.1 North America Covid Testing Kit Revenue by Type (2021-2026)
- 8.2.2 North America Covid Testing Kit Revenue by Type (2027-2032)
- 8.3 North America Covid Testing Kit Revenue Share by Type (2021-2032)
- 8.4 North America Covid Testing Kit Revenue by Application (2021-2032)
- 8.4.1 North America Covid Testing Kit Revenue by Application (2021-2026)
- 8.4.2 North America Covid Testing Kit Revenue by Application (2027-2032)
- 8.5 North America Covid Testing Kit Revenue Share by Application (2021-2032)
- 8.6 North America Covid Testing Kit Revenue by Country
- 8.6.1 North America Covid Testing Kit Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Covid Testing Kit Revenue by Country (2021-2026)
- 8.6.3 North America Covid Testing Kit Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Covid Testing Kit Revenue (2021-2032)
- 9.2 Europe Covid Testing Kit Revenue by Type (2021-2032)
- 9.2.1 Europe Covid Testing Kit Revenue by Type (2021-2026)
- 9.2.2 Europe Covid Testing Kit Revenue by Type (2027-2032)
- 9.3 Europe Covid Testing Kit Revenue Share by Type (2021-2032)
- 9.4 Europe Covid Testing Kit Revenue by Application (2021-2032)
- 9.4.1 Europe Covid Testing Kit Revenue by Application (2021-2026)
- 9.4.2 Europe Covid Testing Kit Revenue by Application (2027-2032)
- 9.5 Europe Covid Testing Kit Revenue Share by Application (2021-2032)
- 9.6 Europe Covid Testing Kit Revenue by Country
- 9.6.1 Europe Covid Testing Kit Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Covid Testing Kit Revenue by Country (2021-2026)
- 9.6.3 Europe Covid Testing Kit Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Covid Testing Kit Revenue (2021-2032)
- 10.2 China Covid Testing Kit Revenue by Type (2021-2032)
- 10.2.1 China Covid Testing Kit Revenue by Type (2021-2026)
- 10.2.2 China Covid Testing Kit Revenue by Type (2027-2032)
- 10.3 China Covid Testing Kit Revenue Share by Type (2021-2032)
- 10.4 China Covid Testing Kit Revenue by Application (2021-2032)
- 10.4.1 China Covid Testing Kit Revenue by Application (2021-2026)
- 10.4.2 China Covid Testing Kit Revenue by Application (2027-2032)
- 10.5 China Covid Testing Kit Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Covid Testing Kit Revenue (2021-2032)
- 11.2 Asia Covid Testing Kit Revenue by Type (2021-2032)
- 11.2.1 Asia Covid Testing Kit Revenue by Type (2021-2026)
- 11.2.2 Asia Covid Testing Kit Revenue by Type (2027-2032)
- 11.3 Asia Covid Testing Kit Revenue Share by Type (2021-2032)
- 11.4 Asia Covid Testing Kit Revenue by Application (2021-2032)
- 11.4.1 Asia Covid Testing Kit Revenue by Application (2021-2026)
- 11.4.2 Asia Covid Testing Kit Revenue by Application (2027-2032)
- 11.5 Asia Covid Testing Kit Revenue Share by Application (2021-2032)
- 11.6 Asia Covid Testing Kit Revenue by Country
- 11.6.1 Asia Covid Testing Kit Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Covid Testing Kit Revenue by Country (2021-2026)
- 11.6.3 Asia Covid Testing Kit Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Covid Testing Kit Revenue (2021-2032)
- 12.2 SAMEA Covid Testing Kit Revenue by Type (2021-2032)
- 12.2.1 SAMEA Covid Testing Kit Revenue by Type (2021-2026)
- 12.2.2 SAMEA Covid Testing Kit Revenue by Type (2027-2032)
- 12.3 SAMEA Covid Testing Kit Revenue Share by Type (2021-2032)
- 12.4 SAMEA Covid Testing Kit Revenue by Application (2021-2032)
- 12.4.1 SAMEA Covid Testing Kit Revenue by Application (2021-2026)
- 12.4.2 SAMEA Covid Testing Kit Revenue by Application (2027-2032)
- 12.5 SAMEA Covid Testing Kit Revenue Share by Application (2021-2032)
- 12.6 SAMEA Covid Testing Kit Revenue by Country
- 12.6.1 SAMEA Covid Testing Kit Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Covid Testing Kit Revenue by Country (2021-2026)
- 12.6.3 SAMEA Covid Testing Kit Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst